Controversy Surrounds Penny Mordaunt's Appointment at British American Tobacco

Apr.11.2025
Controversy Surrounds Penny Mordaunt's Appointment at British American Tobacco
Former UK Conservative Party leadership candidate and defense minister Penny Mordaunt joins BAT advisory role, raising ethical concerns.

Key Points:

Former UK Conservative Party leadership candidate and Defense Minister Penny Mordaunt has accepted a consultancy position with British American Tobacco (BAT), advising on harm reduction strategies.

The Business Appointments Consultative Committee pointed out that former cabinet ministers like Mordaunt may provide unfair government access opportunities for British American Tobacco and advised him to avoid direct contact with the government.

Anti-smoking organizations are skeptical of the "harm reduction" promises made by British American Tobacco, as they rely on cigarette sales. They question whether the appointment of Mordaunt is in the public interest.


According to The Guardian's report on April 10th, Penny Mordaunt, a former British Conservative Party leadership candidate who has held several cabinet positions including Defense Secretary and Leader of the House of Commons, has taken on a new role as an advisor for British American Tobacco (BAT), responsible for providing guidance on "harm reduction.

 

In 2024, after losing her seat in parliament, she will be working as a paid consultant for the Transformation Advisory Group at British American Tobacco (BAT).

 

The senator abstained from voting on the gradual smoking ban proposed by Rishi Sunak last year, and was in charge of managing the government's legislative agenda before the bill failed to pass parliament before the election.

 

The Labour Party had urged the government to break with tradition and push forward with the Tobacco and E-cigarette Bill, even though it was in the initial stages at the time. With the Labour Party pushing for it, the bill has once again been put on the agenda.

 

Penny Mordaunt's new job was disclosed by the Advisory Committee on Business Appointments, which stipulates that she cannot lobby for the government or engage in any public contracts consulting within two years of leaving office.

 

The committee pointed out that "British American Tobacco has a keen interest in government policies and regulations, and focuses resources on influencing government decisions - such as lobbying for lower tobacco taxes, enacting e-cigarette legislation, and preventing counterfeit goods.

 

The committee stated that due to changes in government and the passage of time, the risk of Mordaunt gaining access to potentially helpful information regarding British American Tobacco is limited.

 

However, the committee added, "Although you claim not to engage in lobbying, your previous role as a cabinet minister may be perceived as providing unfair access to and influence over the government for British American Tobacco. Therefore, the committee recommends that you should not represent the company directly in dealings with the government, as this would pose a significant risk under government regulations.

 

Anti-smoking activists are skeptical of tobacco companies' claims of "reducing harm," believing that these companies rely on cigarette sales.

 

In recent years, it has been unusual for former ministers to work for tobacco companies, and several members of parliament have been criticized for accepting hospitality from the tobacco industry. Ken Clarke, a former Conservative Chancellor and Health Secretary, worked at British American Tobacco from 1998 to 2007.

 

Regarding the appointment of Mordaunt, Kingsley Wheaton, the Chief Corporate Officer of British American Tobacco, stated,

 

British American Tobacco has launched a manifesto of change... It is based on the best practices of Tobacco Harm Reduction (THR) and science. To accelerate this goal, we are aware that challenging our conventional thinking with alternative perspectives will greatly contribute to success. The THR Advisory Committee is designed for this purpose.

 

At present, Mordaunt has not yet made any comments on the matter.

 

Main image source: Ian Forsyth/Getty Images

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Germany's Four-Year Tobacco Tax Plan Heads to Parliament as BAT, JTI and PMI Push for Changes
Germany's Four-Year Tobacco Tax Plan Heads to Parliament as BAT, JTI and PMI Push for Changes
Germany's parliament is scheduled to hold a first reading of amendments to the Tobacco Tax Act on September 24. The government plans annual tax increases from 2027 through 2030 covering cigarettes, heated tobacco, vaping liquids and other categories. It expects the reform to generate €756 million in additional revenue in 2027, rising to €3.589 billion in additional annual revenue by 2030. Ahead of the parliamentary debate, the German Association of the Tobacco Industry and Novel Products, or BVTE, launched the "Tabaksteuer mit Augenmaß" campaign backed by BAT, JTI, Philip Morris, Reemtsma and wholesale and retail groups.
Sep.23
Sweden Finds ZYN Ingredient Labels Noncompliant Over Generic Flavoring Disclosure, Swedish Match Faces SEK 2 Million Monthly Penalty
Sweden Finds ZYN Ingredient Labels Noncompliant Over Generic Flavoring Disclosure, Swedish Match Faces SEK 2 Million Monthly Penalty
Sweden's Public Health Agency has found ingredient labels on ZYN nicotine pouches sold by Philip Morris International subsidiary Swedish Match to be noncompliant, according to Dagens industri. The products' packaging listed 10 to 13 ingredients, compared with 11 to 42 in regulatory submissions, with multiple flavoring ingredients grouped under the generic term "aromer." The agency ordered corrective action, warning of a conditional penalty of SEK 2 million per month for noncompliance. The order applies only to products manufactured after the decision becomes legally effective and does not require recalls. Swedish Match disputes the agency's interpretation and plans to appeal.
PMI
Oct.22
Product | OXVA Introduces XLIM PRO 4 With Liquid-Level Anti-Burn Technology and Dedicated Pods
Product | OXVA Introduces XLIM PRO 4 With Liquid-Level Anti-Burn Technology and Dedicated Pods
Vaping brand OXVA introduced the XLIM PRO 4 refillable pod system in October 2026, featuring Anti-Burn Tech (ABT) based on smart e-liquid-level detection. The system can issue refill alerts and stop power output when e-liquid levels become too low. ABT requires the XLIM PRO 4 device and a dedicated XLIM ABT cartridge. Standard XLIM pods remain compatible but do not support ABT protection. OXVA previously introduced temperature-based anti-burn technology in the XLIM Pro 2 DNA, developed with Evolv. The new device features a 1,800mAh battery, 5–30W output and a 0.98-inch HD color screen. OXVA's official store lists the device at $37.90 and dedicated ABT replacement cartridges at $12.99. Independent testing confirmed the low-liquid protection response but recorded varying cartridge lifespans.
product
Oct.30
How Investors Are Repricing the Global Tobacco Industry as Nicotine Markets Shift
How Investors Are Repricing the Global Tobacco Industry as Nicotine Markets Shift
How are investors reassessing the global tobacco industry as nicotine markets evolve? In an interview with 2Firsts, Charlie Chen, Head of Research at CCB International Securities, forecasts annual growth of 30–50% for nicotine pouches, outpacing vaping and heated tobacco. He examines how regulatory enforcement, shifting market shares and new business models are influencing company valuations. The report also explores differences between multinational tobacco groups and Chinese companies, drawing on insights from the New Approaches Summit on profitability, investment strategies and industry consolidation.
Nov.11
As Regulators Focus on Nicotine Pouch Child Safety, Safeguard Pursues an External Packaging Route
As Regulators Focus on Nicotine Pouch Child Safety, Safeguard Pursues an External Packaging Route
As regulators pay closer attention to child safety in nicotine pouches, manufacturers face a practical challenge: how to strengthen child-resistant packaging without unnecessarily reworking products, production lines and regulatory submissions already in place. In a written interview with 2Firsts, Chemular detailed Safeguard’s external packaging approach, its customer-specific testing requirements and possible PMTA pathways. The model remains early-stage, but it offers a new way to think about an increasingly important regulatory and manufacturing issue.
Industry Insight
Sep.19
Reynolds Showcases Vuse Pro Flavors and VELO Nicotine Pouches at NACS Show 2026
Reynolds Showcases Vuse Pro Flavors and VELO Nicotine Pouches at NACS Show 2026
Reynolds American, a BAT subsidiary, showcased four Vuse Pro flavored e-cigarette pods and its VELO nicotine pouch portfolio at NACS Show 2026. Booth staff confirmed to 2Firsts that the Vuse Pro flavors are sold in the U.S., although they have not received FDA marketing authorization. BAT outlined plans to expand Vuse retail distribution and reported that VELO held a 30.5% year-to-date volume share of the U.S. modern oral nicotine category through August 2026. The booth also featured the newly launched VELO MAX range and merchandising displays combining cigarettes, vaping products and oral nicotine brands.
EXPO
Oct.09